Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of oral trehalose in traumatic head injury patients in ICU
IRCT20210508051223N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2022
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of trehalose in traumatic brain injury (TBI) and Intracranial Injury, sponsored by Mashhad University of Medical Sciences. Started May 2022; status: completed.
02
Drugs
trehalose
03
Conditions
traumatic brain injury (TBI)Intracranial Injury
Beyond the preview
Go deeper on IRCT20210508051223N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210508051223N1.